Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Pulmonary Embolism After Endovascular Aortic Repair, a Retrospective Cohort Study.

Grobben RB, Frima C, Nathoe HM, Leiner T, Kwakkel-van Erp JM, van Klei WA, Peelen LM, van Herwaarden JA.

Eur J Vasc Endovasc Surg. 2019 Feb;57(2):304-310. doi: 10.1016/j.ejvs.2018.08.054. Epub 2018 Oct 20.

PMID:
30348482
2.

Diabetes, but Not Hypertension and Obesity, Is Associated with Postoperative Cognitive Dysfunction.

Lachmann G, Feinkohl I, Borchers F, Ottens TH, Nathoe HM, Sauer AM, Dieleman JM, Radtke FM, van Dijk D, Spies C, Pischon T.

Dement Geriatr Cogn Disord. 2018;46(3-4):193-206. doi: 10.1159/000492962. Epub 2018 Oct 16.

PMID:
30326480
3.

Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus.

de Vries TI, Kappelle LJ, van der Graaf Y, de Valk HW, de Borst GJ, Nathoe HM, Visseren FLJ, Westerink J; SMART study group.

Acta Diabetol. 2019 Apr;56(4):431-440. doi: 10.1007/s00592-018-1231-y. Epub 2018 Sep 27.

PMID:
30259116
4.

Causes and prevention of postoperative myocardial injury.

Verbree-Willemsen L, Grobben RB, van Waes JA, Peelen LM, Nathoe HM, van Klei WA, Grobbee DE.

Eur J Prev Cardiol. 2019 Jan;26(1):59-67. doi: 10.1177/2047487318798925. Epub 2018 Sep 12.

5.

Association of obesity, diabetes and hypertension with cognitive impairment in older age.

Feinkohl I, Lachmann G, Brockhaus WR, Borchers F, Piper SK, Ottens TH, Nathoe HM, Sauer AM, Dieleman JM, Radtke FM, van Dijk D, Pischon T, Spies C.

Clin Epidemiol. 2018 Jul 25;10:853-862. doi: 10.2147/CLEP.S164793. eCollection 2018.

6.

Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.

van Kleef MEAM, Visseren FLJ, Vernooij JWP, Nathoe HM, Cramer MM, Bemelmans RHH, van der Graaf Y, Spiering W; SMART-study group.

J Hypertens. 2018 Sep;36(9):1865-1873. doi: 10.1097/HJH.0000000000001785.

PMID:
29878973
7.

Round-the-clock performance of coronary CT angiography for suspected acute coronary syndrome: Results from the BEACON trial.

Lubbers MM, Dedic A, Kurata A, Dijkshoorn M, Schaap J, Lammers J, Lamfers EJ, Rensing BJ, Braam RL, Nathoe HM, Post JC, Rood PP, Schultz CJ, Moelker A, Ouhlous M, van Dalen BM, Boersma E, Nieman K.

Eur Radiol. 2018 May;28(5):2169-2175. doi: 10.1007/s00330-017-5082-7. Epub 2017 Dec 15.

8.

Unexpected Cardiac Computed Tomography Findings in Patients With Postoperative Myocardial Injury.

Grobben RB, van Waes JAR, Leiner T, Peelen LM, de Borst GJ, Vogely HC, Grobbee DE, Doevendans PA, van Klei WA, Nathoe HM; CHASE Investigators.

Anesth Analg. 2018 May;126(5):1462-1468. doi: 10.1213/ANE.0000000000002580.

PMID:
29099425
9.

Relation between adiposity and vascular events, malignancy and mortality in patients with stable cerebrovascular disease.

Jaspers NEM, Dorresteijn JAN, van der Graaf Y, Westerink J, Kappelle LJ, Nathoe HM, Algra A, Visseren FLJ.

Int J Obes (Lond). 2017 Dec;41(12):1775-1781. doi: 10.1038/ijo.2017.184. Epub 2017 Aug 4.

PMID:
28775374
10.

Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.

van der Sande NGC, Visseren FLJ, van der Graaf Y, Nathoe HM, de Borst GJ, Leiner T, Blankestijn PJ; SMART Study Group.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):921-928. doi: 10.2215/CJN.08990816. Epub 2017 May 9.

11.

Determinants of the postpericardiotomy syndrome: a systematic review.

van Osch D, Nathoe HM, Jacob KA, Doevendans PA, van Dijk D, Suyker WJ, Dieleman JM.

Eur J Clin Invest. 2017 Jun;47(6):456-467. doi: 10.1111/eci.12764. Epub 2017 May 15. Review.

PMID:
28425090
12.

Relation of Epicardial Adipose Tissue Radiodensity to Coronary Artery Calcium on Cardiac Computed Tomography in Patients at High Risk for Cardiovascular Disease.

Franssens BT, Nathoe HM, Visseren FL, van der Graaf Y, Leiner T; SMART Study Group.

Am J Cardiol. 2017 May 1;119(9):1359-1365. doi: 10.1016/j.amjcard.2017.01.031. Epub 2017 Feb 11.

PMID:
28279438
13.

No psychological distress in sportsmen aged 45 years and older after cardiovascular screening, including cardiac CT: The Measuring Athlete's Risk of Cardiovascular events (MARC) study.

Schurink MM, Braber TL, Prakken NH, Doevendans PA, Backx FJ, Grobbee DE, Rienks R, Nathoe HM, Bots ML, Velthuis BK, Mosterd A.

Neth Heart J. 2017 Apr;25(4):271-277. doi: 10.1007/s12471-017-0948-5.

14.

Brain volume and cognitive function in patients with revascularized coronary artery disease.

Ottens TH, Hendrikse J, Nathoe HM, Biessels GJ, van Dijk D.

Int J Cardiol. 2017 Mar 1;230:80-84. doi: 10.1016/j.ijcard.2016.12.079. Epub 2016 Dec 21.

15.

Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery.

van Osch D, Dieleman JM, Bunge JJ, van Dijk D, Doevendans PA, Suyker WJ, Nathoe HM; Dexamethasone for Cardiac Surgery Study Group.

J Thorac Cardiovasc Surg. 2017 Apr;153(4):878-885.e1. doi: 10.1016/j.jtcvs.2016.10.075. Epub 2016 Nov 15.

PMID:
27919456
16.

Relation between cardiovascular disease risk factors and epicardial adipose tissue density on cardiac computed tomography in patients at high risk of cardiovascular events.

Franssens BT, Nathoe HM, Leiner T, van der Graaf Y, Visseren FL; SMART study group.

Eur J Prev Cardiol. 2017 Apr;24(6):660-670. doi: 10.1177/2047487316679524. Epub 2016 Jan 1.

PMID:
27872327
17.

Submillisievert coronary calcium quantification using model-based iterative reconstruction: A within-patient analysis.

den Harder AM, Wolterink JM, Willemink MJ, Schilham AMR, de Jong PA, Budde RPJ, Nathoe HM, Išgum I, Leiner T.

Eur J Radiol. 2016 Nov;85(11):2152-2159. doi: 10.1016/j.ejrad.2016.09.028. Epub 2016 Sep 30.

PMID:
27776671
18.

Kinetics of troponin I in patients with myocardial injury after noncardiac surgery.

van Waes JA, Peelen LM, Kemperman H, Grobben RB, Nathoe HM, van Klei WA.

Clin Chem Lab Med. 2017 Mar 1;55(4):586-594. doi: 10.1515/cclm-2016-0301.

PMID:
27732551
19.

Plasma CTGF is independently related to an increased risk of cardiovascular events and mortality in patients with atherosclerotic disease: the SMART study.

Gerritsen KG, Falke LL, van Vuuren SH, Leeuwis JW, Broekhuizen R, Nguyen TQ, de Borst GJ, Nathoe HM, Verhaar MC, Kok RJ, Goldschmeding R, Visseren FL; SMART Study Group.

Growth Factors. 2016 Aug;34(3-4):149-58. doi: 10.1080/08977194.2016.1210142.

PMID:
27686612
20.

Response to Comment on Sharif et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 2016;39:1424-1430.

Sharif S, van der Graaf Y, Nathoe HM, de Valk HW, Visseren FL, Westerink J; SMART Study Group.

Diabetes Care. 2016 Oct;39(10):e190-1. doi: 10.2337/dci16-0023. No abstract available.

PMID:
27660133
21.

Aortic Valve and Thoracic Aortic Calcification Measurements: How Low Can We Go in Radiation Dose?

van Hamersvelt RW, den Harder AM, Willemink MJ, Schilham AM, Lammers JJ, Nathoe HM, Budde RP, Leiner T, de Jong PA.

J Comput Assist Tomogr. 2017 Jan;41(1):148-155. doi: 10.1097/RCT.0000000000000477.

PMID:
27560017
22.

Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.

van den Berg MJ, van der Graaf Y, de Borst GJ, Kappelle LJ, Nathoe HM, Visseren FLJ; SMART Study Group.

Am J Cardiol. 2016 Sep 15;118(6):804-810. doi: 10.1016/j.amjcard.2016.06.048. Epub 2016 Jun 28.

23.

Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes.

Franssens BT, Westerink J, van der Graaf Y, Nathoe HM, Visseren FLJ; SMART study group.

Int J Cardiol. 2016 Nov 1;222:72-77. doi: 10.1016/j.ijcard.2016.07.081. Epub 2016 Jul 5.

PMID:
27458826
24.

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.

Bots SH, van der Graaf Y, Nathoe HM, de Borst GJ, Kappelle JL, Visseren FL, Westerink J; SMART Study Group.

Cardiovasc Diabetol. 2016 Jul 19;15(1):101. doi: 10.1186/s12933-016-0418-1.

25.

Re: 'Lost in Translation: Time to Re-evaluate Our Definitions'.

Grobben RB, Nathoe HM, van Klei WA, de Borst GJ.

Eur J Vasc Endovasc Surg. 2016 Aug;52(2):270. doi: 10.1016/j.ejvs.2016.05.003. Epub 2016 Jun 2. No abstract available.

26.

HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.

Sharif S, van der Graaf Y, Nathoe HM, de Valk HW, Visseren FL, Westerink J; SMART Study Group.

Diabetes Care. 2016 Aug;39(8):1424-30. doi: 10.2337/dc16-0155. Epub 2016 May 23.

PMID:
27222511
27.

Occult coronary artery disease in middle-aged sportsmen with a low cardiovascular risk score: The Measuring Athlete's Risk of Cardiovascular Events (MARC) study.

Braber TL, Mosterd A, Prakken NH, Rienks R, Nathoe HM, Mali WP, Doevendans PA, Backx FJ, Bots ML, Grobbee DE, Velthuis BK.

Eur J Prev Cardiol. 2016 Oct;23(15):1677-84. doi: 10.1177/2047487316651825. Epub 2016 May 24.

PMID:
27222386
28.

Added Value of Female-Specific Factors Beyond Traditional Predictors for Future Cardiovascular Disease.

van der Meer MG, van der Graaf Y, Schuit E, Peelen LM, Verschuren WM, Boer JM, Moons KG, Nathoe HM, Appelman Y, van der Schouw YT.

J Am Coll Cardiol. 2016 May 3;67(17):2084-6. doi: 10.1016/j.jacc.2016.02.031. No abstract available.

29.

One-Year Mortality, Causes of Death, and Cardiac Interventions in Patients with Postoperative Myocardial Injury.

van Waes JA, Grobben RB, Nathoe HM, Kemperman H, de Borst GJ, Peelen LM, van Klei WA; Cardiac Health After Surgery (CHASE) Investigators.

Anesth Analg. 2016 Jul;123(1):29-37. doi: 10.1213/ANE.0000000000001313.

PMID:
27111647
30.

Response to 'Re: Clinical Relevance of Cardiac Troponin Assessment in Patients Undergoing Carotid Endarterectomy'.

Grobben RB, Nathoe HM, van Klei WA, de Borst GJ.

Eur J Vasc Endovasc Surg. 2016 Apr;51(4):607. doi: 10.1016/j.ejvs.2015.12.007. Epub 2016 Feb 6. No abstract available.

31.

Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study.

Dedic A, Lubbers MM, Schaap J, Lammers J, Lamfers EJ, Rensing BJ, Braam RL, Nathoe HM, Post JC, Nielen T, Beelen D, le Cocq d'Armandville MC, Rood PP, Schultz CJ, Moelker A, Ouhlous M, Boersma E, Nieman K.

J Am Coll Cardiol. 2016 Jan 5;67(1):16-26. doi: 10.1016/j.jacc.2015.10.045.

32.

Association of High Ankle Brachial Index With Incident Cardiovascular Disease and Mortality in a High-Risk Population.

Hendriks EJ, Westerink J, de Jong PA, de Borst GJ, Nathoe HM, Mali WP, van der Graaf Y, van der Schouw YT, Beulens JW; SMART Study Group.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):412-7. doi: 10.1161/ATVBAHA.115.306657. Epub 2015 Dec 29.

PMID:
26715681
33.

Clinical Relevance of Cardiac Troponin Assessment in Patients Undergoing Carotid Endarterectomy.

Grobben RB, Vrijenhoek JE, Nathoe HM, Den Ruijter HM, van Waes JA, Peelen LM, van Klei WA, de Borst GJ.

Eur J Vasc Endovasc Surg. 2016 Apr;51(4):473-80. doi: 10.1016/j.ejvs.2015.09.023. Epub 2015 Nov 6.

34.

Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.

Nijhoff F, Stella PR, Troost MS, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Agostoni P.

Clin Res Cardiol. 2016 May;105(5):401-11. doi: 10.1007/s00392-015-0934-0. Epub 2015 Nov 5.

35.

Hypertensive Target Organ Damage and Longitudinal Changes in Brain Structure and Function: The Second Manifestations of Arterial Disease-Magnetic Resonance Study.

van der Veen PH, Geerlings MI, Visseren FL, Nathoe HM, Mali WP, van der Graaf Y, Muller M; SMART Study Group.

Hypertension. 2015 Dec;66(6):1152-8. doi: 10.1161/HYPERTENSIONAHA.115.06268. Epub 2015 Oct 26.

PMID:
26503971
36.

Finding the optimal dose reduction and iterative reconstruction level for coronary calcium scoring.

Willemink MJ, den Harder AM, Foppen W, Schilham AM, Rienks R, Laufer EM, Nieman K, de Jong PA, Budde RP, Nathoe HM, Leiner T.

J Cardiovasc Comput Tomogr. 2016 Jan-Feb;10(1):69-75. doi: 10.1016/j.jcct.2015.08.004. Epub 2015 Aug 28.

PMID:
26342405
37.

Intraoperative High-Dose Dexamethasone in Cardiac Surgery and the Risk of Rethoracotomy.

van Osch D, Dieleman JM, Nathoe HM, Boasson MP, Kluin J, Bunge JJ, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, van Dijk D; Dexamethasone for Cardiac Surgery Study Group.

Ann Thorac Surg. 2015 Dec;100(6):2237-42. doi: 10.1016/j.athoracsur.2015.06.025. Epub 2015 Aug 25.

PMID:
26319483
38.

The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease.

Kranenburg G, van der Graaf Y, van der Leeuw J, Nathoe HM, de Borst GJ, Kappelle LJ, Visseren FL, Westerink J; SMART Study Group.

Diabetes Care. 2015 Oct;38(10):1930-6. doi: 10.2337/dc15-0493. Epub 2015 Aug 25.

PMID:
26307606
39.

Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.

Nijhoff F, Agostoni P, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S34-44. doi: 10.1002/ccd.26060. Epub 2015 Jun 29.

PMID:
26119971
40.

Sex-specific chest pain characteristics.

van der Meer MG, Nathoe HM, Appelman Y.

JAMA Intern Med. 2015 Apr;175(4):650. doi: 10.1001/jamainternmed.2014.8060. No abstract available.

PMID:
25844738
41.

Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography.

Gijsberts CM, Gohar A, Ellenbroek GH, Hoefer IE, de Kleijn DP, Asselbergs FW, Nathoe HM, Agostoni P, Rittersma SZ, Pasterkamp G, Appelman Y, den Ruijter HM.

Atherosclerosis. 2015 Jul;241(1):234-40. doi: 10.1016/j.atherosclerosis.2015.02.002. Epub 2015 Feb 4.

PMID:
25670231
42.

Dexamethasone for the prevention of postoperative atrial fibrillation.

van Osch D, Dieleman JM, van Dijk D, Jacob KA, Kluin J, Doevendans PA, Nathoe HM; DExamethasone for Cardiac Surgery (DECS) study group; DExamethasone for Cardiac Surgery DECS study group.

Int J Cardiol. 2015 Mar 1;182:431-7. doi: 10.1016/j.ijcard.2014.12.094. Epub 2015 Jan 8.

PMID:
25596472
43.

Cause-specific mortality and years of life lost in patients with different manifestations of vascular disease.

van Kruijsdijk RC, van der Graaf Y, Koffijberg H, de Borst GJ, Nathoe HM, Jaap Kappelle L, Visseren FL; SMART study group.

Eur J Prev Cardiol. 2016 Jan;23(2):160-9. doi: 10.1177/2047487314566998. Epub 2015 Jan 16.

PMID:
25595551
44.

The diagnostic value of clinical symptoms in women and men presenting with chest pain at the emergency department, a prospective cohort study.

van der Meer MG, Backus BE, van der Graaf Y, Cramer MJ, Appelman Y, Doevendans PA, Six AJ, Nathoe HM.

PLoS One. 2015 Jan 15;10(1):e0116431. doi: 10.1371/journal.pone.0116431. eCollection 2015.

45.

Worse outcome in women with STEMI: a systematic review of prognostic studies.

van der Meer MG, Nathoe HM, van der Graaf Y, Doevendans PA, Appelman Y.

Eur J Clin Invest. 2015 Feb;45(2):226-35. doi: 10.1111/eci.12399. Review.

PMID:
25556757
46.

Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.

van de Woestijne AP, van der Graaf Y, Westerink J, Nathoe HM, Visseren FL.

Am J Cardiol. 2015 Feb 15;115(4):441-6. doi: 10.1016/j.amjcard.2014.11.021. Epub 2014 Nov 29.

PMID:
25554536
47.

The effects of intraoperative dexamethasone on left atrial function and postoperative atrial fibrillation in cardiac surgical patients.

Jacob KA, Dieleman JM, Nathoe HM, van Osch D, de Waal EE, Cramer MJ, Kluin J, van Dijk D.

Neth Heart J. 2015 Mar;23(3):168-73. doi: 10.1007/s12471-014-0638-5.

48.

The relation between resting heart rate and cancer incidence, cancer mortality and all-cause mortality in patients with manifest vascular disease.

van Kruijsdijk RC, van der Graaf Y, Bemelmans RH, Nathoe HM, Peeters PH, Visseren FL; SMART Study Group.

Cancer Epidemiol. 2014 Dec;38(6):715-21. doi: 10.1016/j.canep.2014.09.004. Epub 2014 Oct 17.

PMID:
25448083
49.

Rationale and design of the Measuring Athlete's Risk of Cardiovascular events (MARC) study : The role of coronary CT in the cardiovascular evaluation of middle-aged sportsmen.

Braber TL, Mosterd A, Prakken NH, Doevendans PA, Mali WP, Backx FJ, Grobbee DE, Rienks R, Nathoe HM, Bots ML, Velthuis BK.

Neth Heart J. 2015 Feb;23(2):133-8. doi: 10.1007/s12471-014-0630-0.

50.

Perioperative troponin elevation: always myocardial injury, but not always myocardial infarction.

Nathoe HM, van Klei WA, Beattie WS.

Anesth Analg. 2014 Nov;119(5):1014-6. doi: 10.1213/ANE.0000000000000422. No abstract available.

PMID:
25329016

Supplemental Content

Loading ...
Support Center